Standout Papers

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy 2025 202617
  1. A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy (2025)
    Wanqiong Li, Xin Yang et al. Nature Communications

Immediate Impact

1 from Science/Nature 51 standout
Sub-graph 1 of 23

Citing Papers

Pancreatic cancer
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
2 intermediate papers

Works of Xin Yang being referenced

Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy
2023
Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy
2023
and 1 more

Author Peers

Author Last Decade Papers Cites
Xin Yang 394 604 389 136 1.7k
Yasuhiro Ogawa 334 468 306 174 2.0k
Hui Yuan 300 473 307 128 1.7k
Feng Tian 176 430 360 101 1.5k
Christoph Mundhenke 388 693 876 106 2.2k
Jianzhong Ai 354 707 395 122 1.7k
Xuan Wang 405 539 392 161 2.0k
Juanjuan Xu 330 661 314 80 2.0k
Takeshi Tamaki 220 447 319 92 1.7k
Jie Song 316 810 444 114 1.9k
Xueqin Chen 414 444 294 153 1.7k

All Works

Loading papers...

Rankless by CCL
2026